ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On June 15, 2021, the board of directors (the "Board") of Genius Brands
International, Inc. (the "Company") increased the size of the Board from eight
to nine members and appointed Dr. Cynthia Turner-Graham to serve as a member of
the Board, effective immediately.
Cynthia Turner-Graham, MD, is a board-certified psychiatrist and Distinguished
Life Fellow of the American Psychiatric Association, who brings over 40 years of
experience in the healthcare industry as a practicing psychiatrist, healthcare
administrator and community leader. Among her accomplishments, Dr. Turner-Graham
is the immediate past president of the Suburban Maryland Psychiatric Society,
served as a Director of the Washington Psychiatric Society. and will take the
helm of Black Psychiatrists of America as President in 2022. She has served as
Clinical Assistant Professor of Psychiatry at both Vanderbilt University and
Howard University Schools of Medicine.
There were no arrangements or understandings between Dr. Turner-Graham and any
other person pursuant to which Dr. Turner-Graham was appointed as a director.
There are no transactions to which the Company is a party and in which Dr.
Turner-Graham has a material interest that is required to be disclosed under
Item 404(a) of Regulation S-K. Dr. Turner-Graham has not previously held any
positions with the Company and has no family relationships with any directors or
executive officers of the Company.
As a non-employee director, Dr. Turner-Graham is entitled to receive cash
compensation in accordance with the arrangements in effect for non-employee
directors of the Company.
2
© Edgar Online, source Glimpses